Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer

被引：0
|
作者：
Kaye, Frederic J. [1 ]
Jantz, Michael A. [1 ]
Dallas, Jennifer [1 ]
机构：
[1] Univ Florida, Coll Med, Gainesville, FL 32611 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2011年 / 364卷 / 24期
关键词：
RECHALLENGE; DISEASE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2367 / 2367
页数：1
相关论文
共 50 条
  • [31] Erlotinib in previously treated non-small-cell lung cancer
    Shepherd, FA
    Pereira, JR
    Ciuleanu, T
    Tan, EH
    Hirsh, V
    Thongprasert, S
    Campos, D
    Maoleekoonpiroj, S
    Smylie, M
    Martins, R
    van Kooten, M
    Dediu, M
    Findlay, B
    Tu, DS
    Johnston, D
    Bezjak, A
    Clark, G
    Santabárbara, P
    Seymour, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 123 - 132
  • [32] Gefitinib therapy for advanced non-small-cell lung cancer
    Liu, CY
    Seen, S
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1644 - 1653
  • [33] Gefitinib or docetaxel in advanced non-small-cell lung cancer
    Cullen, Michael
    Thatcher, Nicholas
    LANCET, 2008, 372 (9652): : 1785 - 1786
  • [34] Clinical experience with erlotinib in non-small-cell lung cancer
    Felip, Enriqueta
    Rosell, Rafael
    DRUGS OF TODAY, 2006, 42 (03) : 147 - 156
  • [35] STABLE ISOTOPE RESOLVED METABOLOMICS OF ERLOTINIB AND GEFITINIB RESISTANT NON-SMALL-CELL LUNG CANCER (NSCLC) CELL LINES
    Mader, Robert M.
    Joerger, Markus
    Vychalkovskiy, Anton
    Jaeger, Walter
    DRUG METABOLISM REVIEWS, 2015, 47 : 147 - 147
  • [36] Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib
    Li, Xiaoqin
    Liu, Shan
    Gu, Hangang
    Wang, Deqiang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (11) : 1963 - 1969
  • [37] Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib
    Xiaoqin Li
    Shan Liu
    Hangang Gu
    Deqiang Wang
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1963 - 1969
  • [38] Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
    Shao, Yu-Yun
    Shau, Wen-Yi
    Lin, Zhong-Zhe
    Chen, Ho-Min
    Kuo, Raymond
    Yang, James Chih-Hsin
    Lai, Mei-Shu
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (01) : 106 - 114
  • [39] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [40] Gefitinib plus clocetaxel in non-small-cell lung cancer Reply
    Kim, Edward S.
    Watkins, Claire L.
    Armour, Alison A.
    Douillard, Jean-Yves
    LANCET, 2009, 373 (9663): : 542 - 542
12345